Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Venous Thromboembolism × Cyclosporine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 90 Leukemia 87 Precursor Cell Lymphoblastic Leukemia-Lymphoma 85 Myelodysplastic Syndromes 73 Leukemia, Lymphocytic, Chronic, B-Cell 72 Lymphoma, Non-Hodgkin 67 Multiple Myeloma 58 Lymphoma, Mantle-Cell 58 Hodgkin Disease 58 Lymphoma, Large B-Cell, Diffuse 55 Lymphoma 55 Lymphoma, Follicular 53 Leukemia, Myeloid, Chronic-Phase 51 Lymphoma, B-Cell, Marginal Zone 48 Burkitt Lymphoma 48 Lymphoma, Large-Cell, Immunoblastic 44 Leukemia, Myeloid, Accelerated Phase 44 Leukemia, Myelomonocytic, Chronic 40 Congenital Abnormalities 40 Myeloproliferative Disorders 38 Anemia, Refractory, with Excess of Blasts 36 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 34 Graft vs Host Disease 33 Blast Crisis 31 Recurrence 29 Dendritic Cell Sarcoma, Interdigitating 29 Primary Myelofibrosis 25 Lymphoma, T-Cell, Cutaneous 24 Neoplasms, Plasma Cell 23 Sezary Syndrome 22

Interventions

apixaban 15 Dalteparin 14 Rivaroxaban 11 Enoxaparin 9 Tinzaparin 7 Heparin, Low-Molecular-Weight 7 Aspirin 7 Warfarin 3 Fondaparinux 3 edoxaban 2 bemiparin 2 abelacimab 2 Rosuvastatin Calcium 2 Nadroparin 2 MAA868 2 Dabigatran 2 sotorasib 1 reviparin 1 enoxaparin sodium 1 certoparin 1 betrixaban 1 argatroban 1 acarboxyprothrombin 1 Tacrolimus 1 Tablets 1 Simvastatin 1 Platelet Transfusion 1 Phenprocoumon 1 Observation 1 N(4)-oleylcytosine arabinoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03083782 2017-10-11

ACT

Thomas Jefferson University

Phase 1 Completed

Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡